Search | PALTmed

Showing 2041 - 2050 of 7790 results

JAMDA

October 28, 2019

Deprescribing as a Clinical Improvement Focus

Polypharmacy is a concern in the practice of geriatrics because of consequences such as adverse drug events and poorer quality of life. Deprescribing, a response to polypharmacy, refers to the systematic, programmed, and appropriate reduction in drug number and dose. Although now broadly recognized, challe...

Chapter Event

Dec 11, 2024 7:00 pm - Dec 11, 2024 8:00 pm

Deprescribing Benzos in Older Adults

NYSPALTC Webinar

JAMDA

August 6, 2021

Deprescribing Blood Pressure Treatment in Long-Term Care Residents

To evaluate the incidence of deprescribing of antihypertensive medication among older adults residing in Veterans Affairs (VA) nursing homes for long-term care and rates of deprescribing after potentially triggering events.

JAMDA

January 23, 2023

Deprescribing Glucose-Lowering Therapy in Older Adults with Diabetes: A Systematic Review of Recommendations

JAMDA

October 25, 2018

Deprescribing in Geriatric Medicine: Challenges and Opportunities

JAMDA

March 7, 2019

Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors

To assess 1-year incidence and factors related to deprescribing in nursing home (NH) residents in Europe.

JAMDA

June 26, 2019

Deprescribing in Nursing Homes

JAMDA

February 23, 2017

Deprescribing in the Nursing Home: Phase 1 - PRN Medications

JAMDA

April 27, 2023

Deprescribing Initiative Fostering Enhanced Quality of Life in Post-acute

JAMDA

August 12, 2023

Deprescribing Interventions for Older Patients: A Systematic Review and Meta-Analysis

Deprescribing reduces polypharmacy in older adults. A thorough study of the effect of deprescribing interventions on clinical outcomes in older adults is presently lacking. As a result, we evaluated the impact of deprescribing on clinical outcomes in older patients.